Official record
Measure details
- Jurisdiction
- Delaware
- Session
- 153
- Chamber
- lower
- Classification
- bill
- Subjects
- Not supplied
- Introduced / first action
- 2026-05-19 00:00:00
Alternate titles
- Biologics/Biosimilars/Step Therapy/Updates short title
Source-supplied abstracts
This Act modernizes Delaware law by adding modern medical treatment options biologics or biosimilars to the step therapy exception process. The current law was passed before biosimilars were widely available. Biosimilars are to biologics what generic drugs are to traditional drugs once their exclusivity expires. This revision adds an exclusion to step therapy protocol exceptions for interchangeable biologics and biosimilars.
Sponsors
- Melissa Minor-Brown (primary), primary
- Marie Pinkney (primary), primary
- Russell Huxtable (primary), primary
- Ray Seigfried (primary), primary
- Eric Morrison (primary), primary
- Bryant L. Richardson (primary), primary
- Kerri Evelyn Harris (primary), primary
- Stell Parker Selby (primary), primary
- William J. Carson (primary), primary
- Spiros Mantzavinos (primary), primary
- Melanie Ross Levin (primary), primary
- Claire Snyder-Hall (primary), primary
- Nicole Poore (primary), primary